A citation-based method for searching scientific literature

Najah Mighri, Yosr Hamdi, Maroua Boujemaa, Houcemeddine Othman, Sonia Ben Nasr, Houda El Benna, Nesrine Mejri, Soumaya Labidi, Jihen Ayari, Olfa Jaidene, Hanen Bouaziz, Mariem Ben Rekaya, Ridha M'rad, Abderrazek Haddaoui, Khaled Rahal, Hamouda Boussen, Samir Boubaker, Sonia Abdelhak. Front Genet 2020
Times Cited: 6







List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.
Fatima-Zahra Laarabi, Ilham Ratbi, Siham Chafai Elalaoui, Loubna Mezzouar, Yassamine Doubaj, Laila Bouguenouch, Karim Ouldim, Noureddine Benjaafar, Abdelaziz Sefiani. BMC Res Notes 2017
16
83

Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Asma Fourati, Marie-Michèle Louchez, Joelle Fournier, Amor Gamoudi, Khaled Rahal, Michèle-Véronique El May, Ahmed El May, Françoise Revillion, Jean-Philippe Peyrat. Bull Cancer 2014
22
83

Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.
Wafa Troudi, N Uhrhammer, C Sibille, C Dahan, W Mahfoudh, C Bouchlaka Souissi, T Jalabert, L Chouchane, Y J Bignon, F Ben Ayed,[...]. J Hum Genet 2007
44
83

Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
A Riahi, M Kharrat, M E Ghourabi, F Khomsi, A Gamoudi, I Lariani, A E May, K Rahal, H Chaabouni-Bouhamed. Clin Genet 2015
38
83

Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
Wijden Mahfoudh, Noureddine Bouaouina, Slim Ben Ahmed, Sallouha Gabbouj, Jingxuan Shan, Rebecca Mathew, Nancy Uhrhammer, Yves-Jean Bignon, Wafa Troudi, Amel Ben Ammar Elgaaied,[...]. Mol Biol Rep 2012
54
83

BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.
Farid Cherbal, Rabah Bakour, Saida Adane, Kada Boualga, Gaelle Benais-Pont, Philippe Maillet. Dis Markers 2010
36
83

Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco.
Joaira Bakkach, Mohamed Mansouri, Touria Derkaoui, Ali Loudiyi, ElMostafa El Fahime, Amina Barakat, Naima Ghailani Nourouti, Jaime Martinez De Villarreal, Carlos Cortijo Bringas, Mohcine Bennani Mechita. BMC Cancer 2020
5
80

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer.
Sarra Henouda, Assia Bensalem, Rym Reggad, Nedda Serrar, Leila Rouabah, Pascal Pujol. Dis Markers 2016
14
66

Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Aouatef Riahi, Mohamel El Ghourabi, Asma Fourati, Habiba Chaabouni-Bouhamed. Breast Cancer 2017
13
50

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis.
Rong Bu, Abdul K Siraj, Khadija A S Al-Obaisi, Shaham Beg, Mohsen Al Hazmi, Dahish Ajarim, Asma Tulbah, Fouad Al-Dayel, Khawla S Al-Kuraya. Int J Cancer 2016
35
50

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.
Sandrine Caputo, Louisa Benboudjema, Olga Sinilnikova, Etienne Rouleau, Christophe Béroud, Rosette Lidereau. Nucleic Acids Res 2012
66
50

Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia.
Wijden Mahfoudh, Inchirah Bettaieb, Randa Ghedira, Kaouther Snoussi, Nadia Bouzid, Zahra Klayech, Sallouha Gabbouj, Yassmine Remadi, Elham Hassen, Noureddine Bouaouina,[...]. J Transl Med 2019
11
50


BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
Abdelilah Laraqui, Nancy Uhrhammer, Hicham E L Rhaffouli, Yassine Sekhsokh, Idriss Lahlou-Amine, Tahar Bajjou, Farida Hilali, Jamila El Baghdadi, Abderrahmane Al Bouzidi, Youssef Bakri,[...]. Dis Markers 2015
27
50

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Yael Laitman, Tara M Friebel, Drakoulis Yannoukakos, Florentia Fostira, Irene Konstantopoulou, Gisella Figlioli, Bernardo Bonanni, Siranoush Manoukian, Monica Zuradelli, Carlo Tondini,[...]. Hum Mutat 2019
14
50


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.
Jing Zhang, James D Fackenthal, Yonglan Zheng, Dezheng Huo, Ningqi Hou, Qun Niu, Cecilia Zvosec, Temidayo O Ogundiran, Anselm J Hennis, Maria Cristina Leske,[...]. Breast Cancer Res Treat 2012
37
50

Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.
Jaco Oosthuizen, Maritha J Kotze, Nicole Van Der Merwe, Ettienne J Myburgh, Phillip Bester, Nerina C van der Merwe. Front Oncol 2021
6
50

BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
Amal Tazzite, Hassan Jouhadi, Sellama Nadifi, Paolo Aretini, Elisabetta Falaschi, Anita Collavoli, Abdellatif Benider, Maria Adelaide Caligo. Gynecol Oncol 2012
41
50

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
Dorra Ben Ayed-Guerfali, Wala Ben Kridis-Rejab, Nihel Ammous-Boukhris, Wajdi Ayadi, Slim Charfi, Afef Khanfir, Tahia Sellami-Boudawara, Mounir Frikha, Jamel Daoud, Raja Mokdad-Gargouri. J Transl Med 2021
4
75

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
Fatima Zahra El Ansari, Farah Jouali, Nabila Marchoudi, Mohcine Mechita Bennani, Naima Nourouti Ghailani, Amina Barakat, Jamal Fekkak. BMC Cancer 2020
5
60

BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Chiraz Mehemmai, Farid Cherbal, Yosr Hamdi, Abdelmoumene Guedioura, Wassila Benbrahim, Rabah Bakour, Sonia Abdelhak. Pathol Oncol Res 2020
5
60

First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene.
Farah Jouali, Fatima-Zahra Laarabi, Nabila Marchoudi, Ilham Ratbi, Siham Chafai Elalaoui, Houria Rhaissi, Jamal Fekkak, Abdelaziz Sefiani. Oncol Lett 2016
13
50

Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.
Abdelilah Laraqui, Nancy Uhrhammer, Idriss Lahlou-Amine, Hicham El Rhaffouli, Jamila El Baghdadi, Mohamed Dehayni, Rahali Driss Moussaoui, Mohamed Ichou, Yassir Sbitti, Abderrahman Al Bouzidi,[...]. Int J Med Sci 2013
42
50

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
50

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Orland Díez, Ana Osorio, Mercedes Durán, José Ignacio Martinez-Ferrandis, Miguel de la Hoya, Raquel Salazar, Ana Vega, Berta Campos, Raquel Rodríguez-López, Eladio Velasco,[...]. Hum Mutat 2003
136
33

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.
Carolina Alvarez, Teresa Tapia, Elisa Perez-Moreno, Patricia Gajardo-Meneses, Catalina Ruiz, Mabel Rios, Claudio Missarelli, Mariela Silva, Adolfo Cruz, Luis Matamala,[...]. Oncotarget 2017
19
33

[Breast cancer in Tunisia: epidemiologic characteristics and trends in incidence].
M Ben Abdallah, S Zehani, M Maalej, M Hsairi, M Hechiche, K Ben Romdhane, H Boussen, A Saadi, N Achour, F Ben Ayed. Tunis Med 2009
17
33

Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
Yosr Hamdi, Maroua Boujemaa, Mariem Ben Rekaya, Cherif Ben Hamda, Najah Mighri, Houda El Benna, Nesrine Mejri, Soumaya Labidi, Nouha Daoud, Chokri Naouali,[...]. J Transl Med 2018
24
33


Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.
Axel Muendlein, Bettina H Rohde, Klaus Gasser, Anton Haid, Stephanie Rauch, Elena Kinz, Heinz Drexel, Wera Hofmann, Verena Schindler, Rita Kapoor,[...]. J Cancer Res Clin Oncol 2015
18
33

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
33

Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.
Hassan Jouhadi, Amal Tazzite, Houssine Azeddoug, Asmâa Naim, Sellama Nadifi, Abdellatif Benider. BMC Res Notes 2016
7
33

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
33

BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.
Nagi S El Saghir, Nathalie K Zgheib, Hussein A Assi, Katia E Khoury, Yannick Bidet, Sara M Jaber, Raghid N Charara, Rania A Farhat, Firas Y Kreidieh, Stephanie Decousus,[...]. Oncologist 2015
36
33

On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
Nancy Hamel, Bing-Jian Feng, Lenka Foretova, Dominique Stoppa-Lyonnet, Steven A Narod, Evgeny Imyanitov, Olga Sinilnikova, Laima Tihomirova, Jan Lubinski, Jacek Gronwald,[...]. Eur J Hum Genet 2011
67
33

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Mads Thomassen, Thomas V O Hansen, Ake Borg, Henriette Theilmann Lianee, Friedrik Wikman, Inge Søkilde Pedersen, Marie Luise Bisgaard, Finn C Nielsen, Torben A Kruse, Anne-Marie Gerdes. Acta Oncol 2008
39
33


The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
M R Akbari, T Donenberg, J Lunn, D Curling, T Turnquest, E Krill-Jackson, S Zhang, S A Narod, J Hurley. Clin Genet 2014
45
33

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.
Supriya Behl, Nancy Hamel, Manon de Ladurantaye, Stéphanie Lepage, Réjean Lapointe, Anne-Marie Mes-Masson, William D Foulkes. Sci Rep 2020
13
33

The contribution of BRCA1 and BRCA2 to ovarian cancer.
Susan J Ramus, Simon A Gayther. Mol Oncol 2009
116
33

A novel BRCA2 in frame deletion in a Tunisian woman with early onset sporadic breast cancer.
N Hadiji-Abbes, F Trifa, M Choura, A Khabir, T Sellami-Boudawara, M Frikha, J Daoud, R Mokdad-Gargouri. Pathol Biol (Paris) 2015
7
33

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.
Zakaria Einbeigi, Annika Bergman, Jeanne M Meis-Kindblom, Anna Flodin, Cecilia Bjursell, Tommy Martinsson, Lars-Gunnar Kindblom, Jan Wahlström, Arne Wallgren, Margareta Nordling,[...]. Fam Cancer 2007
13
33

[Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
S Mestiri, K Monastiri, S Ben Ahmed, N Bouaouina, N Presneau, Y J Bignon, H Khairi, L Chouchane. Arch Inst Pasteur Tunis 2000
7
33

Founder mutations in BRCA1 and BRCA2 genes.
R Ferla, V Calò, S Cascio, G Rinaldi, G Badalamenti, I Carreca, E Surmacz, G Colucci, V Bazan, A Russo. Ann Oncol 2007
157
33

Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients.
Meryam El Khachibi, Brehima Diakite, Khalil Hamzi, Abdallah Badou, Mohamed Amine Senhaji, Amina Bakhchane, Hassan Jouhadi, Abdelhamid Barakat, Abdellatif Benider, Sellama Nadifi. BMC Cancer 2015
9
33

Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.
Bifeng Zhang, James D Fackenthal, Qun Niu, Dezheng Huo, Walmy E Sveen, Tiffani DeMarco, Clement A Adebamowo, Temidayo Ogundiran, Olufunmilayo I Olopade. Fam Cancer 2009
18
33

Identification of a founder BRCA1 mutation in the Moroccan population.
F Quiles, À Teulé, N Martinussen Tandstad, L Feliubadaló, E Tornero, J Del Valle, M Menéndez, M Salinas, V Wethe Rognlien, A Velasco,[...]. Clin Genet 2016
10
33

Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique.
Salwa H Gomaa Mogahed, Yasser S Hamed, Yassmin E Ibrahim Moursy, Marwa H Mahomoud Saied. Asian Pac J Cancer Prev 2020
2
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.